Microencapsulated Mammalian Cells for Simultaneous Production of VEGF₁₆₅b and IFNα

Figures & data

Figure 1. Photomicrograph of alginate-poly-L-lysine-alginate microcapsules (A) APA microcapsules without cells (B) APA microcapsules containing co-encapsulated engineered cells producing IFNα and engineered cells producing VEGF₁₆₅b.

Figure 2. The number of viable co-microencapsulated cells determined by MTS assay. The capsules contain VEGF₁₆₅b producing HEK293 cells and IFNα producing HEK293 cells.

Figure 3. Western blot analysis of human IFNα and human VEGF₁₆₅b produced by co-encapsulated cells. (A) Production of IFNα (B) production of VEGF₁₆₅b at various time periods

Figure 4. The quantity of secreted IFNα and VEGF₁₆₅b from co-encapsulated cells determined by ELISA.

Figure 5. The quantity of secreted IFNα and VEGF₁₆₅b from non-encapsulated cells determined by ELISA.